Prøve GULL - Gratis
Science & Grit: The Making of New Antibiotics
Mint New Delhi
|September 09, 2025
The world desperately needs new antibiotics. A set of Indian scientists and entrepreneurs are diving in

Over a decade ago, global pharma major AstraZeneca started pulling out of anti-infectives research. In 2014, it shuttered an Indian research site in Bengaluru, axing early-stage research on neglected tropical diseases, tuberculosis, and malaria.
At the same time, in the same city, Bugworks, a biotech firm, was taking shape. A group of scientists and executives from AstraZeneca came on board, embarking on drug research around infectious diseases.
Founded by Anand Anandkumar, Balasubramanian V., Santanu Datta and Shahul Hameed, the company set its sights on a growing global crisis—antimicrobial resistance. There is a dire need for new antibiotics as existing drugs are losing efficacy. Bacteria evolve to grow immune to medicines meant to kill them.
The company has raised close to $43 million in funding since inception and has two novel antibiotic drug candidates in the pipeline—one in phase I trials and the second at the preclinical stage. A drug candidate is a molecule which has passed initial discovery and is being further studied.
The biotech's genesis exemplifies a larger story. As Big Pharma started vacating infectious diseases research to chase more lucrative segments like oncology and diabetes, it left behind a gaping void. A handful of plucky innovators in India, the world's generic pharmacy, are addressing the gap, weathering financial storms and scientific uncertainty to give the world much-needed new antibiotics.
In early 2024, Chennai-based Orchid Pharma's molecule, Enmetazobactam, became the first new chemical entity discovered in India to be approved by the US Food and Drug Administration (FDA). Drugmaker Wockhardt has over five novel antibiotics in its pipeline, with two already rolled out in India.
Denne historien er fra September 09, 2025-utgaven av Mint New Delhi.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint New Delhi

Mint New Delhi
H-1B fee hike spells gloom for Indian IT
Bigger firms may handle costs better, other sectors affected too
3 mins
September 22, 2025

Mint New Delhi
Govt scans prices for profiteering as tax cuts kick in
As the biggest reform in India's goods and services taxes (GST) rolls out today, the Centre will be monitoring whether companies actually pass on the tax cuts or keep the gains to themselves.
3 mins
September 22, 2025

Mint New Delhi
ChrysCapital to whip up a $200 million dessert storm
India-focused private equity firm ChrysCapital is sweetening its portfolio with a $200-million push into the desserts space, following last month's acquisition of patisserie chain Theobroma, two people familiar with the matter said on condition of anonymity.
2 mins
September 22, 2025

Mint New Delhi
Why has Trump's H-1B fee spooked GCCs in India?
1 How big is India's GCC segment?
2 mins
September 22, 2025
Mint New Delhi
HOW CHINA PREPPED FOR THE TARIFF CRISIS
Chinese goods exports grew by 4.1% in year-on-year terms in August. It was the slowest rate in six months, and its worst performance since the US' Donald Trump administration imposed tariffs on almost all economies.
3 mins
September 22, 2025
Mint New Delhi
DATA RECAP: THE WEEK IN CHARTS
From the early impact of US tariffs on India's exports, modest growth in foodgrain production, women facing higher levels of unemployment, and the government looking to mobilize $1 billion in green finance-here is a compilation of this week's news in numbers, curated by Nandita Venkatesan.
2 mins
September 19, 2025

Mint New Delhi
Sebi clears Adani of Hindenburg charge
The stock market regulator on Thursday cleared Adani Group and its top executives of allegations of bypassing related-party transaction rules levelled by Hindenburg Research, bringing the curtains down on an episode that has stretched out across 15 months.
3 mins
September 19, 2025
Mint New Delhi
The CEA's optimism
Could the recent thaw in India-US ties result in tariffs being lowered sharply on Indian exports?
1 min
September 19, 2025

Mint New Delhi
Blackstone looks to buy Zelestra India
New Blackstone RE platform likely; JP Morgan running deal
2 mins
September 19, 2025

Mint New Delhi
How junk feeds profits, starves young bodies
The food industry has trapped children into unhealthy diets, with calorie-dense ultra-processed food dominating shops and schools, Unicef warns in its report Feeding Profit: How Food Environments are Failing Children. Mint unpacks what's at stake for India and world.
2 mins
September 19, 2025
Listen
Translate
Change font size